Monday, June 17, 2024
HomeTagsRelyvrio

Relyvrio

FDA Approves New Treatment Option for Patients with ALS

The U.S. Food and Drug Administration approved Relyvrio (sodium phenylbutyrate/taurursodiol) to treat patients with amyotrophic lateral sclerosis (ALS), commonly referred to as Lou Gehrig's...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics